跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方盐酸利多卡因注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Lidocaine Hydrochloride Injection
Approved
化学药品
Compound Lidocaine Hydrochloride Injection
灵宝市豫西药业有限责任公司
🇨🇳 National Medical Products Administration
Approval Date
Aug 31, 2020
Approval ID
7Leaf0ds0UJ
Company
灵宝市豫西药业有限责任公司
Type
化学药品
Approval Details
Approval Id
7Leaf0ds0UJ
Approval Number
国药准字H20056313
Generic Name
复方盐酸利多卡因注射液
Generic Name En
Compound Lidocaine Hydrochloride Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
5ml:盐酸利多卡因40mg,薄荷脑6.5mg
Reg Date
2020-08-31
Company Name
灵宝市豫西药业有限责任公司
Company Address
灵宝市车站路西段
Production Company Name
灵宝市豫西药业有限责任公司
Production Company Address
灵宝市车站路西段
Company Detail Path
/organization/ling-bao-shi-yu-xi-yao-ye-you-xian-ze-ren-gong-si
Production Company Detail Path
/organization/ling-bao-shi-yu-xi-yao-ye-you-xian-ze-ren-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 31, 2020
Approval ID
7Leaf0ds0UJ
Type
化学药品
Back to NMPA Approvals